| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |